日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors.

利用补体途径抑制剂增强纳米药物在多种物种间的免疫相容性和血液相容性

Li Yue, Jacques Sarah, Gaikwad Hanmant, Nebbia Morgan, Banda Nirmal K, Holers V Michael, Tomlinson Stephen A, Scheinman Robert I, Monte Andrew, Saba Laura, Lasda Erika, Hasselberth Jay, Busquet Nicolas, Zelek Wioleta M, Moghimi S Moein, Simberg Dmitri

Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin.

优化酶联免疫吸附试验,用于检测健康供体和接受聚乙二醇化脂质体阿霉素治疗的患者体内的抗聚乙二醇抗体

Li Yue, Ettah Utibeabasi, Jacques Sarah, Gaikwad Hanmant, Monte Andrew, Dylla Layne, Guntupalli Saketh, Moghimi S Moein, Simberg Dmitri